vedolizumab

pharmaceutical drug

Details

Instance of: type of chemical entity
Subclass of: chemical compound
Has parts: carbon
active ingredient in: Entyvio
defined daily dose: 5.4
has characteristic: biopharmaceutical
has use: medication
medical condition treated: graft-versus-host disease, ulcerative colitis, colitis
pregnancy category: US pregnancy category B
subject has role: gastrointestinal agent, monoclonal antibody
World Health Organisation international non-proprietary name: vedolizumab

Nothing in the MetaHistoryBook collection references this item yet.